In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending ...

The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...

Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

The scientists at the University of California, San Francisco and Johns Hopkins University in Baltimore injected an antisense ...

If 14 million lost coverage, that would push the total number of uninsured in the U.S. close to pre-Affordable Care Act ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

GOP lawmakers tested the limits of how far they could push Kennedy without appearing to undermine him or his MAHA movement.

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

But multiple federal reports indicated that the law fell short, as insurance companies routinely exploited loopholes to avoid ...

At the hearing, Cassidy plans to encourage reforms at HHS but also push for RFK Jr. to include Congress in his efforts.

U.S. drug overdose deaths fell 27% in 2024, the lowest since 2019, with fentanyl cases sharply down but methamphetamine up, ...